Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine > Articles > “Medicine is Deeply Relational: The Human Heart of Oncology in the Age of AI”
  • Articles
  • Profiles

“Medicine is Deeply Relational: The Human Heart of Oncology in the Age of AI”

  • 27 April 2026
  • Knarik Arakelyan
“Medicine is Deeply Relational: The Human Heart of Oncology in the Age of AI”
Total
0
Shares
0
0
0
0
0

From genetics to palliative care, clinician-scientist Rita Canário reflects on building a career in Oncology  that bridges research, patient care, and the human side of medicine and why this integration is essential for the future of oncology.

For Dr Rita Canário, the path into medicine was not predetermined, but discovered gradually, and almost unexpectedly at the intersection of curiosity, creativity, and human connection.

“I was never the type who always wanted to be a doctor,” she says. “I had very eclectic interests from arts to science and choosing a path at 15 felt far too early.”

Initially drawn to genetics, she imagined a future in research. But a formative volunteering experience helping stroke patients during mealtimes shifted her perspective.

“I realised I enjoyed listening to people’s stories and helping them… and that I felt comfortable in the hospital.”

Medicine offered something unique: the possibility of combining scientific inquiry with direct human impact. Oncology, in turn, brought this duality into its most intense and meaningful form.

“It is an area where we combine cutting-edge research with deep human connection.”

A Career Shaped Between Disciplines

Canário’s professional identity today spans clinical oncology, hereditary cancer research, and palliative care—a combination that reflects both intention and necessity.

Her early fascination with genetics naturally led her to hereditary cancer. But it was during medical school and oncology training that she recognised a critical gap in palliative care particularly in Portugal, where services were still underdeveloped.

“I felt the need to become more skilled in end-of-life care,” she explains. This led her to the UK, where she undertook advanced training in palliative care, with the aim of bringing those competencies back into her oncology practice.

For Canário, integrating these domains is not optional; it is fundamental to quality care.

“Combining research with clinical care is the cornerstone of good oncology practice. My end goal is always to improve patients’ lives.”

Her work is guided not only by scientific curiosity, but by the realities patients face.

“Patients centre me. They guide the questions I ask in research.”

The Art of Medicine in a Technological Age

Alongside her scientific training, Canário’s background in the arts has played a defining role in shaping how she practices medicine.

Having attended an artistic school from an early age, she developed a sensitivity to narrative, expression, and human experience skills she now considers essential in oncology.

“Medicine is an art. We must know the science but to deal with people, we cannot neglect emotional intelligence and culture.”

Now teaching at the School of Medicine –  University of Minho, she is part of a curriculum that places medical humanities at its core, an approach she believes is increasingly urgent.

“We are living in a fast-paced world where AI will, hopefully, replace us in several mechanical tasks,” she says. “What will remain is empathy, kindness and the human touch.”

Listening, in this context, becomes a clinical skill as much as a human one.

 From left to right Dr Judy Paulo–Medical oncologist, Prof. Zacharoula Sidiropoulou– Oncologic Surgeon, Dr Rita Canário: ESO Improving outcomes & leadership course in Zagreb, 2025

“When we truly listen to patients’ stories, we are not only building relationships, we are also improving diagnosis and understanding their priorities.”

This, she argues, is the foundation of genuinely personalised medicine: not only tailoring treatment to tumour biology, but to the individual person.

Challenging the Research–Clinic Divide

Despite the clear benefits of integrating research and clinical care, structural barriers remain. In Portugal, there is still no defined pathway for clinician-scientists—a reality that continues to shape Canário’s career.

“I am still struggling to tailor my path and advocating for this career to exist,” she says.

A pivotal moment came during her fellowship at the Royal Marsden Hospital in London, where she saw a different model in action.

“There were colleagues doing research and still seeing patients. That was when I realised this path was possible and meaningful.”

“When we conduct research, we are ‘obliged’ to stay updated and to think methodologically. It improves the care we provide,” noted Dr Canário. 

Yet the challenges are tangible: slower progression, less stability, and financial trade-offs. Even so, she remains committed.

“Passion is a great fuel, it helps to overcome obstacles.”

She is also clear that not every clinician needs to follow this path. Strong oncology teams, she argues, depend on diversity of roles, but they must include individuals who can bridge disciplines.

The Value of Networks, Mentorship and the European School of Oncology

Throughout her career, international exposure and collaboration have played a crucial role, particularly through her long-standing engagement with the European School of Oncology.

From early e-learning initiatives well ahead of their time to masterclasses, fellowships, and structured mentorship programmes, ESO provided opportunities that extended far beyond national training structures. For Canário, these experiences were not only educational, but transformative in shaping both her clinical perspective and her professional trajectory.

“The Clinical Training Centres Fellowship was life changing. It showed me that combining research and clinical care was not only possible, but impactful.”

Mentorship, in particular, proved decisive.

“The mentorship programme came at a crucial time, during the final stage of my PhD. Having Fedro A. Peccatori as a  mentor helped me clarify my career goals and navigate uncertainty. It’s something I now strongly advocate for both receiving and providing mentorship.”

Dr Canário with her ESO mentor Fedro A. Peccatory at ESO masterclass in Barcelona, 2022

“One of the most important lessons from ESO is the value of mentorship and the responsibility to mentor others,” she added. 

Beyond individual development, she emphasises the power of networks in shaping sustainable careers and enabling meaningful impact.

“ESO shows that you don’t necessarily need to leave your country to grow. You can build international collaborations and bring change locally, supported by a strong network.”

In this sense, ESO is not just an educational platform, but a framework for professional identity, one that reinforces the integration of research, clinical practice, and mentorship as interconnected pillars of modern oncology.

When Research and Care Inform Each Other

In her daily work, the interplay between research and clinical practice is constant.

Advances in genetic testing, next-generation sequencing, and digital pathology are transforming oncology, but they also demand clinicians who can critically interpret and integrate complex data.

“Being involved in research allows me to analyse results more deeply and to communicate effectively with colleagues across disciplines,” she says. “Clinician-scientists connect worlds that should never have been separated.”

Equally, clinical experience reshapes research questions.

“When designing studies, I bring a different perspective—understanding disease trajectories, treatment timing, and patient realities. This improves the quality of research design.”

The Emotional Dimension of Oncology

Oncology is as emotionally demanding as it is intellectually complex. For Canário, maintaining empathy requires conscious balance.

“I am deeply involved with my patients, and that is precisely why I don’t want to do full-time clinics,” she says. Research and teaching act as “buffers” that sustain her emotional availability.

Beyond professional structure, personal life plays a critical role. Family, friendships, and creative outlets—including a long-standing book club—are essential sources of resilience.

She also speaks candidly about the challenges of combining motherhood with an academic career.

“I had my son during my PhD, and it was very challenging to return to full performance,” she says. “I often felt that we cannot have it all.”

Rather than individualising the issue, she sees it as systemic—one that future generations must address more effectively.

Rethinking What Patient-Centred Care Means

For Canário, patient-centred care is often misunderstood as a soft concept, when in fact it requires rigor and evidence.

“Evidence-based practice applies to everything—from the drugs we prescribe to the words we say.”

Communication, empathy, and relational skills are not innate traits, but competencies that must be developed and continuously refined.

“Nothing is negligible in the medical–patient relationship,” she emphasises.

Looking Ahead

As oncology evolves, Canário sees integration not specialisation alone as the defining challenge.

“We cannot separate research, patient care, and teaching.” she says. “This is the only way forward.”

In a future shaped by artificial intelligence, the uniquely human aspects of medicine will become even more valuable.

“What will remain uniquely ours is the ability to connect, to understand, and to care.”

For Canário, success is not measured in titles or recognition, but in contribution.

“My idea of success is to leave the world a bit better for the next generations,” she says.

That includes advocating for clinician-scientist career pathways, mentoring future professionals, and reinforcing a principle she believes must never be lost:

“The patient–doctor relationship is not an optional part of the deal. It is the foundation of everything we do.”

About the Author

Knarik Arakelyan (PhD) is a psychologist and communications professional with over 14 years of experience in public relations, health communication, and public awareness campaigns. She is currently the Managing Editor of “CancerWorld “ magazine, and serves as PR and Communications Officer at “EMERTÉ” Clinic.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • AI in healthcare
  • artificial intelligence in medicine
  • cancer care
  • cancer research
  • canderworld
  • clinical oncology
  • clinician scientist
  • digital pathology
  • doctor patient relationship
  • empathy in medicine
  • evidence based medicine
  • future of healthcare
  • genetics in oncology
  • Healthcare Innovation
  • healthcare leadership
  • hereditary cancer
  • human side of medicine
  • interdisciplinary medicine
  • medical education
  • Medical Humanities
  • medical research
  • Mentorship in Medicine
  • newsletter
  • oncodaily
  • oncology
  • palliative care
  • patient centered care
  • personalized medicine
  • precision medicine
  • translational research
Knarik Arakelyan

Previous Article
  • Articles
  • Profiles

 Isabel Mestres: The Doer

  • 23 April 2026
  • Gevorg Tamamyan
View Post
You May Also Like
View Post
  • Articles
  • Profiles

 Isabel Mestres: The Doer

  • Gevorg Tamamyan
  • 23 April 2026
View Post
  • Articles
  • Policy

OncoCorridor

  • Gevorg Tamamyan
  • 22 April 2026
View Post
  • Articles
  • Delivery of Care

Lived Experience of People Affected by Cancer

  • Adrian Pogacian
  • 31 March 2026
View Post
  • Articles
  • Profiles

Translating Global Excellence into Local Impact: Dr Fatjona Kraja and the Challenge of  Transforming Radiation Oncology in Albania

  • Knarik Arakelyan
  • 27 March 2026
View Post
  • Articles
  • Profiles

“Hope is Constant “: From Isolation and Fear to Connection, Purpose, and Global Impact

  • Kevin Donaghy
  • 25 March 2026
View Post
  • Articles
  • Medicine

Michael Gnant at the Crossroads of Oncology: Precision, Restraint, and the Courage to Challenge Orthodoxy

  • Yeva Margaryan
  • 23 March 2026
View Post
  • Articles
  • Profiles

From Dalian to Houston and Back to Yemen: Bridging the Global Oncology Divide

  • Mohammed Safi
  • 21 March 2026
View Post
  • Medicine
  • News

The Day Immunotherapy Went Off-Patent

  • Amalya Sargsyan
  • 18 March 2026
search
CancerWorld #114 Download CancerWorld #113 Download CancerWorld #112 Download CancerWorld #111 Download CancerWorld #110 Download CancerWorld Special Issue Download CancerWorld #109 Download CancerWorld #108 Download CancerWorld #107 Download CancerWorld #106 Download CancerWorld #105 Download CancerWorld #104 Download CancerWorld #103 Download CancerWorld #102 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • CancerWorld #114 (April 2026)
    • 20 April 2026
  • The Day Immunotherapy Went Off-Patent
    • 18 March 2026
  • CancerWorld #113 (March 2026)
    • 9 March 2026
  • Rethinking Immunotherapy for Pancreatic Cancer: A Universal Approach
    • 16 February 2026
  • CancerWorld #112 (February 2026)
    • 7 February 2026
Article
  • “Medicine is Deeply Relational: The Human Heart of Oncology in the Age of AI”
    • 27 April 2026
  •  Isabel Mestres: The Doer
    • 23 April 2026
  • OncoCorridor
    • 22 April 2026
Social

Would you follow us ?

Contents
  • “Medicine is Deeply Relational: The Human Heart of Oncology in the Age of AI”
    • 27 April 2026
  •  Isabel Mestres: The Doer
    • 23 April 2026
  • Translating Global Excellence into Local Impact: Dr Fatjona Kraja and the Challenge of  Transforming Radiation Oncology in Albania
    • 27 March 2026
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.